Home › Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy clinical trials recruiting in the U.S.
27 studies for Duchenne Muscular Dystrophy are recruiting participants at sites across the United States.
Cities with the most studies
- Little Rock, AR7 studies
- Chicago, IL6 studies
- Sacramento, CA5 studies
- Gainesville, FL5 studies
- Durham, NC5 studies
- Boston, MA5 studies
- Washington, DC5 studies
- Columbus, OH5 studies
- Los Angeles, CA4 studies
- St. Louis, MO4 studies
- Nashville, TN4 studies
- Seattle, WA4 studies
- Norfolk, VA3 studies
- Mountain View, CA3 studies
- Cincinnati, OH3 studies
- Portland, OR3 studies
By state
- Arkansas7 studies
- California7 studies
- District of Columbia5 studies
- Florida5 studies
- Illinois6 studies
- Massachusetts6 studies
- Missouri4 studies
- New York4 studies
- North Carolina6 studies
- Ohio6 studies
- Oregon3 studies
- Pennsylvania4 studies
- Tennessee4 studies
- Texas5 studies
- Virginia4 studies
- Washington4 studies
Recently updated studies
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
RecruitingPhase 3
Ages 7 to 11 · Men · Updated Sep 28, 2026 · NCT07160634Registry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
RecruitingObservational study
Ages 2 and older · Men · Updated Sep 24, 2026 · NCT06564974Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RecruitingPhase 2
Ages 7 to 9 · Men · Updated Sep 18, 2026 · NCT07287189A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
RecruitingPhase 1
Ages 2 and older · Men · Updated Sep 11, 2026 · NCT04626674Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
RecruitingPhase 1
Ages 8 to 18 · Men · Updated Aug 24, 2026 · NCT07172971The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
RecruitingObservational study
0 Days – 3 Years · Men · Updated Aug 19, 2026 · NCT07092540Evaluating VM100 Nutritional Supplement for Improving Quality of Life in Duchenne Muscular Dystrophy Patients
Recruiting
Ages 6 and older · Men · Updated Aug 17, 2026 · NCT07766980Once Weekly Infant Corticosteroid Trial for DMD
RecruitingPhase 4
1 Month – 30 Months · Men · Updated Aug 14, 2026 · NCT05412394Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
RecruitingObservational study
All ages · All sexes · Updated Jul 28, 2026 · NCT07674758A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
RecruitingPhase 1/2
Ages 0 to 17 · Men · Updated Jul 8, 2026 · NCT06138639A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
RecruitingObservational study
Ages 6 and older · All sexes · Updated Jul 2, 2026 · NCT07127978PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
RecruitingPhase 1/2
Ages 2 to 7 · Men · Updated Jun 23, 2026 · NCT07429240Duchenne Electronic Health Record Study
RecruitingObservational study
All ages · All sexes · Updated May 27, 2026 · NCT07609394Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
RecruitingPhase 3
Ages 4 to 18 · Men · Updated May 27, 2026 · NCT07608432Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
RecruitingObservational studyHealthy volunteers welcome
Ages 10 and older · Men · Updated May 22, 2026 · NCT06124196Vasodilator and Exercise Study for DMD (VASO-REx)
RecruitingPhase 2
Ages 6 and older · Men · Updated May 15, 2026 · NCT06290713The Duchenne Registry
RecruitingObservational study
All ages · All sexes · Updated May 8, 2026 · NCT02069756Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Apr 9, 2026 · NCT06839469Urinary Titin Biomarker in DMD
RecruitingHealthy volunteers welcome
Ages 2 to 10 · Men · Updated Apr 8, 2026 · NCT07332013Trial of Cell Based Therapy for DMD
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Mar 4, 2026 · NCT06692426Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
RecruitingPhase 1/2
Ages 4 to 18 · Men · Updated Dec 15, 2025 · NCT04906460Biomarker Development for Muscular Dystrophies
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Nov 24, 2025 · NCT05019625Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
RecruitingObservational study
Ages 5 and older · All sexes · Updated Nov 24, 2025 · NCT05016908Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
RecruitingObservational study
Ages 10 and older · Men · Updated Nov 6, 2025 · NCT06093100Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
RecruitingObservational studyHealthy volunteers welcome
Ages 5 to 62 · Men · Updated Oct 15, 2025 · NCT01484678From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.